Skip to content

Bismuth Subcitrate, Metronidazole and Tetracycline (140 Mg/125 Mg/125 Mg)

Bismuth Subcitrate, Metronidazole and Tetracycline (140 Mg/125 Mg/125 Mg) comes in 1 pill version in our database, in 1 strength, from 1 manufacturer. Check the imprint to tell them apart.

Bismuth Subcitrate, Metronidazole and Tetracycline (140 Mg/125 Mg/125 Mg) pill images

140 mg / 125 mg / 125 mg 1 pill

What is Bismuth Subcitrate, Metronidazole and Tetracycline (140 Mg/125 Mg/125 Mg) used for?

Bismuth Subcitrate, Metronidazole and Tetracycline (140 Mg/125 Mg/125 Mg) is an antibiotic and antiparasitic.

Medicine type
Antibiotic and antiparasitic
Official uses from the US prescribing label

To reduce the development of drug-resistant bacteria and maintain the effectiveness of PYLERA and other antibacterial drugs, PYLERA should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Eradication of Helicobacter pylori in Patients with Active Duodenal Ulcer or History of Duodenal Ulcer Disease

PYLERA in combination with omeprazole are indicated for the treatment of patients with Helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate H. pylori. The eradication of Helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence.

From the FDA-approved label on DailyMed (published Mar 21, 2011).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.